Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Novan, Inc. Novan Enters into Agreement to Sell Substantially All of its Assets, including Berdazimer Gel, 10.3% (SB206), and Files for Chapter 11 Protection July 17, 2023 From Novan, Inc. Via GlobeNewswire Tickers LGND NOVN Novan to Provide Corporate Update at its 2023 Annual Meeting of Stockholders June 05, 2023 From Novan, Inc. Via GlobeNewswire Tickers NOVN Novan Focuses Strategic Direction and Announces Restructuring May 31, 2023 From Novan, Inc. Via GlobeNewswire Tickers NOVN Novan Reports First Quarter 2023 Financial Results and Provides Corporate Update May 15, 2023 From Novan, Inc. Via GlobeNewswire Tickers NOVN Novan to Report First Quarter 2023 Financial Results on May 15, 2023 May 08, 2023 From Novan, Inc. Via GlobeNewswire Tickers NOVN Novan Announces Publication of Psoriasis Patient Data Demonstrating Need for Rapid Symptom Improvement¹ April 27, 2023 From Novan, Inc. Via GlobeNewswire Tickers NOVN Novan to Host Analyst and Investor Event: A Discussion of Molluscum’s Unmet Need with Pediatric Dermatologist Jeffrey Sugarman, MD, PhD April 20, 2023 From Novan, Inc. Via GlobeNewswire Tickers NOVN Novan Reports Full Year 2022 Financial Results and Provides Corporate Update March 30, 2023 From Novan, Inc. Via GlobeNewswire Tickers NOVN Novan to Report Full Year 2022 Financial Results on March 30, 2023 March 23, 2023 From Novan, Inc. Via GlobeNewswire Tickers NOVN Novan Announces Closing of $6.0 Million Registered Direct Offering March 16, 2023 From Novan, Inc. Via GlobeNewswire Tickers NOVN Novan to Present at the Oppenheimer 33rd Annual Healthcare Conference March 14, 2023 From Novan, Inc. Via GlobeNewswire Tickers NOVN Novan Announces $6.0 Million Registered Direct Offering March 14, 2023 From Novan, Inc. Via GlobeNewswire Tickers NOVN Novan Moves Forward with Unified Corporate Branding March 08, 2023 From Novan, Inc. Via GlobeNewswire Tickers NOVN FDA Accepts Novan’s NDA for Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum with a PDUFA Goal Date of January 5, 2024 March 07, 2023 From Novan, Inc. Via GlobeNewswire Tickers NOVN Novan to Present at the Virtual Investor 2023 Companies to Watch Event January 18, 2023 From Novan, Inc. Via GlobeNewswire Tickers NOVN Novan Submits New Drug Application to the U.S. FDA for Berdazimer Gel, 10.3% (SB206) for the Treatment of Molluscum Contagiosum January 06, 2023 From Novan, Inc. Via GlobeNewswire Tickers NOVN EPI Health, a Novan Company, Enters into Exclusive License Agreement with Sato Pharmaceutical Co., Ltd. for RHOFADE® in Japan December 21, 2022 From Novan, Inc. Via GlobeNewswire Tickers NOVN EPI Health, a Novan Company, Executes a $15.0 Million Financing Agreement December 02, 2022 From Novan, Inc. Via GlobeNewswire Tickers HTBK NOVN Novan to Participate in the Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & Medtech Conference December 01, 2022 From Novan, Inc. Via GlobeNewswire Tickers NOVN Novan Reports Third Quarter 2022 Financial Results and Provides Corporate Update November 14, 2022 From Novan, Inc. Via GlobeNewswire Tickers NOVN Novan to Report Third Quarter 2022 Financial Results on November 14, 2022 November 07, 2022 From Novan, Inc. Via GlobeNewswire Tickers NOVN EPI Health, a Novan Company, and MC2 Therapeutics Present New Data In Multiple Posters Highlighting WYNZORA’s® Unique PAD Technology™ at the 42nd Annual Fall Clinical Dermatology Conference® October 21, 2022 From Novan, Inc. Via GlobeNewswire Tickers NOVN EPI Health, a Novan Company, and MC2 Therapeutics Announce Data from Survey Conducted by National Psoriasis Foundation Presented at 42nd Annual Fall Clinical Dermatology Conference® October 21, 2022 From Novan, Inc. Via GlobeNewswire Tickers NOVN Novan and EPI Health, a Novan Company, Announce Abstracts Accepted for Poster Presentation at the 42nd Annual Fall Clinical Dermatology Conference® October 14, 2022 From Novan, Inc. Via GlobeNewswire Tickers NOVN Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.